Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...

The crossover of the bevacizumab and panitumumab survival curves in the PARADIGM study: A clue to time-related effects of bevacizumab on the risk of tumor progression. Risk of peritoneal recurrence ...

“Sadly, very expensive liver transplantation is the only remedy ... “The Somatom Lumina 3 Tesla Magnetic Resonance Imaging (MRI), is a new system that gives full confidence to deliver the ...